Faramand Andrew, Kano Hideyuki, Niranjan Ajay, Atik Ahmet F, Lee Cheng-Chia, Yang Huai-Che, Mohammed Nasser, Liscak Roman, Hanuska Jaromir, Tripathi Manjul, Kondziolka Douglas, Sheehan Jason, Mathieu David, Flickinger John C, Lunsford L Dade
Department of Neurological Surgery and Radiation Oncology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Department of Neurological Surgery, Cleveland Clinic, Cleveland, Ohio.
Neurosurgery. 2021 Mar 15;88(4):791-796. doi: 10.1093/neuros/nyaa538.
Choroid plexus tumors (CPT) are rare epithelial tumors of the choroid plexus. Gross total resection (GTR) may be curative, but it is not always possible.
To evaluate the role of Gamma Knife stereotactic radiosurgery (GKSRS) as either a primary or adjuvant management option for WHO grade I-III CPT through a multicenter project.
A total of 32 patients (20 females) with a total of 43 treated tumors were included in the analysis. A total of 25 patients (78%) had undergone initial surgical resection. The median total tumor volume was 2.2 cc, and the median margin and maximum doses were 13 and 25.5 Gy, respectively.
Local tumor control was achieved in 69% of cases. Local tumor progression-free survival (PFS) rate for low-grade tumors at 1, 3, and 5 yr was 90%, 77%, 58%, respectively. The actuarial local tumor PFS rate for high-grade tumors at 1, 3, and 5 yr was 77%, 62%, and 62%, respectively. There was no significant difference in local tumor control rates between low- and high-grade CPT (P = .3). Gender, age, and degree of resection were not associated with treated tumor PFS. Distant intracranial spread developed in 6 patients at a median of 22 mo after initial SRS. Actuarial distant brain tumor PFS rate at 1, 2, 5, and 10 yr was 93%, 88%, 78%, and 65%, respectively. Three patients (9%) developed persistent symptomatic adverse radiation effects at a median of 11 mo after the procedure.
GKSRS represents a minimally invasive alternative management strategy for imaging defined or surgically recurrent low- and high-grade CPT.
脉络丛肿瘤(CPT)是一种罕见的脉络丛上皮肿瘤。全切除(GTR)可能是治愈性的,但并非总是可行的。
通过多中心项目评估伽玛刀立体定向放射外科(GKSRS)作为 I-III 级 CPT 的主要或辅助治疗选择的作用。
共纳入 32 例(20 例女性)43 个治疗肿瘤的患者。共有 25 例(78%)患者接受了初始手术切除。总肿瘤体积中位数为 2.2cc,边缘和最大剂量中位数分别为 13 和 25.5Gy。
69%的病例达到局部肿瘤控制。低级别肿瘤的局部肿瘤无进展生存(PFS)率分别为 1、3 和 5 年时为 90%、77%和 58%。高级别肿瘤的局部肿瘤 1、3 和 5 年时的无进展生存率分别为 77%、62%和 62%。低级别和高级别 CPT 的局部肿瘤控制率无显著差异(P=0.3)。性别、年龄和切除程度与治疗肿瘤的 PFS 无关。6 例患者在初始 SRS 后中位时间为 22 个月出现远处颅内播散。1、2、5 和 10 年时的远处脑肿瘤 PFS 率分别为 93%、88%、78%和 65%。3 例(9%)患者在术后 11 个月出现持续的症状性放射性不良反应。
GKSRS 代表了一种针对影像学定义或手术复发的低级别和高级别 CPT 的微创替代治疗策略。